In vivo imaging platform for tracking immunotherapeutic cells ET Ahrens, R Flores, H Xu, PA Morel Nature biotechnology 23 (8), 983-987, 2005 | 737 | 2005 |
Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study. PA Morel, JS Dorman, JA Todd, HO McDevitt, M Trucco Proceedings of the National Academy of Sciences 85 (21), 8111-8115, 1988 | 493 | 1988 |
Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function RB Mailliard, YI Son, R Redlinger, PT Coates, A Giermasz, PA Morel, ... The Journal of Immunology 171 (5), 2366-2373, 2003 | 454 | 2003 |
Fluorine‐19 MRI for visualization and quantification of cell migration in a diabetes model M Srinivas, PA Morel, LA Ernst, DH Laidlaw, ET Ahrens Magnetic Resonance in Medicine: An Official Journal of the International …, 2007 | 333 | 2007 |
Crossregulation between Th1 and Th2 cells PA Morel, TB Oriss Critical Reviews™ in Immunology 18 (4), 1998 | 269 | 1998 |
Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A,-B,-Cw,-DRB1, and-DQA1 allelic profiles distinguish European American … TP O'Hanlon, DM Carrick, IN Targoff, FC Arnett, JD Reveille, M Carrington, ... Medicine 85 (2), 111-127, 2006 | 268 | 2006 |
Dendritic cells promote macrophage infiltration and comprise a substantial proportion of obesity-associated increases in CD11c+ cells in adipose tissue and liver M Stefanovic-Racic, X Yang, MS Turner, BS Mantell, DB Stolz, ... Diabetes 61 (9), 2330-2339, 2012 | 242 | 2012 |
Receptor‐mediated endocytosis of iron‐oxide particles provides efficient labeling of dendritic cells for in vivo MR imaging ET Ahrens, M Feili‐Hariri, H Xu, G Genove, PA Morel Magnetic Resonance in Medicine: An Official Journal of the International …, 2003 | 228 | 2003 |
Immunotherapy of NOD mice with bone marrow-derived dendritic cells. M Feili-Hariri, X Dong, SM Alber, SC Watkins, RD Salter, PA Morel Diabetes 48 (12), 2300-2308, 1999 | 208 | 1999 |
Dominant role of antigen dose in CD4+ Foxp3+ regulatory T cell induction and expansion MS Turner, LP Kane, PA Morel The Journal of Immunology 183 (8), 4895-4903, 2009 | 205 | 2009 |
T-bet and eomesodermin are required for T cell-mediated antitumor immune responses Y Zhu, S Ju, E Chen, S Dai, C Li, P Morel, L Liu, X Zhang, B Lu The Journal of Immunology 185 (6), 3174-3183, 2010 | 204 | 2010 |
In vivo cytometry of antigen‐specific t cells using 19F MRI M Srinivas, MS Turner, JM Janjic, PA Morel, DH Laidlaw, ET Ahrens Magnetic Resonance in Medicine: An Official Journal of the International …, 2009 | 185 | 2009 |
Negative regulation of FcϵRI signaling by FcγRII costimulation in human blood basophils CL Kepley, JC Cambier, PA Morel, D Lujan, E Ortega, BS Wilson, ... Journal of allergy and clinical immunology 106 (2), 337-348, 2000 | 169 | 2000 |
Expression of functional CD32 molecules on human NK cells is determined by an allelic polymorphism of the FcγRIIC gene D Metes, LK Ernst, WH Chambers, A Sulica, RB Herberman, PA Morel Blood, The Journal of the American Society of Hematology 91 (7), 2369-2380, 1998 | 168 | 1998 |
Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy M Feili-Hariri, DH Falkner, PA Morel Journal of leukocyte biology 78 (3), 656-664, 2005 | 156 | 2005 |
Crossregulation between T helper cell (Th) 1 and Th2: inhibition of Th2 proliferation by IFN-gamma involves interference with IL-1. TB Oriss, SA McCarthy, BF Morel, MA Campana, PA Morel Journal of immunology (Baltimore, Md.: 1950) 158 (8), 3666-3672, 1997 | 139 | 1997 |
The duration of T cell stimulation is a critical determinant of cell fate and plasticity N Miskov-Zivanov, MS Turner, LP Kane, PA Morel, JR Faeder Science signaling 6 (300), ra97-ra97, 2013 | 138 | 2013 |
Co-aggregation of FcγRII with FcϵRI on human mast cells inhibits antigen-induced secretion and involves SHIP-Grb2-Dok complexes CL Kepley, S Taghavi, G Mackay, D Zhu, PA Morel, K Zhang, JJ Ryan, ... Journal of Biological Chemistry 279 (34), 35139-35149, 2004 | 137 | 2004 |
Dendritic cells, T cell tolerance and therapy of adverse immune reactions PA Morel, M Feili-Hariri, PT Coates, AW Thomson Clinical & Experimental Immunology 133 (1), 1-10, 2003 | 134 | 2003 |
Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin‐13 associated with increased skin fibrosis P Fuschiotti, TA Medsger Jr, PA Morel Arthritis & Rheumatism: Official Journal of the American College of …, 2009 | 133 | 2009 |